The Meeting resolved that the board of directors shall, for the period until the end of the next annual general meeting, continue to consist of six (6) ordinary members.

The Meeting further resolved that the remuneration to the board of directors for the period until the next annual general meeting shall continue to be SEK 415,000 for the chairman of the board of directors and SEK 300,000 to each of the other ordinary board members. Board members shall also be entitled to invoice the Company in so far as they perform services outside the board assignment.

Paolo Fidanza, Halvard Idland and Carlos Gomez-Lackington were re-elected as ordinary board members. Furthermore, Hernán Magariños, Jay Heller and Andrés Rubio were newly elected as ordinary board members, in each case for the period until the end of the next annual general meeting. Paolo Fidanza was re-elected as chairman of the board of directors.

This information was made public, through the agency of the persons below, at 11.35 CEST on 20 August 2026.

The income statements and the balance sheets for the company and the group were approved and the board of directors and the CEO were discharged from liability for the financial year 2025.

The meeting resolved that no dividend shall be paid for the financial year 2025 and that the company’s available funds shall be carried forward in new account.

Paulo Thiago Mendonça, Carlos Gomez-Lackington, Halvard Idland and Fabio Vassel were re-elected as members of the board of directors. Furthermore, Paolo Fidanza and Miles Molyneaux were new-elected as members of the board of directors. Paolo Fidanza was new-elected as chairman of the board.

The meeting approved fees payable to the members of the board of directors and the chairman of the board of directors, including remuneration for committee work, to be as follows:

1. Annual fees of the members of the board of directors of SEK 300,000.
2. Annual fee of the chairman of the board of directors of SEK 415,000.
3. Annual fees of SEK 40,000 to members of the Audit, Ethics and Compliance committee, Remuneration committee, and the ESG committee.
4. Annual fees of SEK 60,000 to the chairman of the Audit, Ethics and Compliance committee, Remuneration committee, and the ESG committee.
5. Members of the board of directors shall be entitled to invoice the company in so far as they perform services outside the board assignment.

The accounting firm Deloitte AB was re-elected as the auditor of the company, with authorised public accountant Andreas Frountzos as the auditor in charge, for a period until the end of the 2027 annual general meeting. The auditor’s fee shall be paid upon approval of their invoice.

The meeting resolved to approve the company’s remuneration report for the financial year 2025.

The meeting resolved to authorise the board of directors to – for the period up to the next annual general meeting and at one (1) or more occasions – resolve upon issuance of new shares, warrants and/or convertible debentures. Payment may be made in cash, in kind, through set-off of claims or otherwise be conditional. The company’s share capital may by support of the authorisation be increased by an amount corresponding to 20 percent of the share capital and number of shares in the company as of on the date the board of directors make use of the authorisation. Deviation from the shareholders’ preferential rights shall be allowed in situations where a directed issue is deemed more appropriate for the company due to timing, commercial or similar reasons, and in order to enable acquisitions.

The meeting resolved on amendments to the policy for remuneration to the senior executives. The policy was adapted to the current company name and the company’s new business operations by replacement of industry-specific references to the oil and gas sector with broader references to the relevant market. The new amended policy applies for the time being, but at the latest until the annual general meeting to be held in 2027.

The meeting further resolved on amendments to the principles for the appointment of a nomination committee. The chairman of the board of directors will no longer be a member of the nomination committee. Instead, the nomination committee will consist of only three (3) members, appointed annually by the three (3) largest shareholders by votes as of 30 September each calendar year. The new amended principles apply until a resolution on a change is resolved on by the meeting.

Miscellaneous

The information was made public, through the agency of the contact persons below, 15:15 CEST on 26 May 2026.

Approval of the transaction

The meeting resolved, in accordance with the board of directors’ proposal, to approve Maha Capital’s acquisition of KEO World, Inc. and its subsidiaries (the KEO Group) by way of a merger with Maha Capital’s U.S. subsidiary Maha Capital US Inc.

New issue of shares with deviation from the shareholders’ preferential rights for delivery of consideration shares

The meeting resolved, in accordance with the board of directors’ proposal, on an issue of no more than 141,050,933 new shares with deviation from the shareholders’ preferential rights, entailing an increase of the share capital by no more than SEK 1,551,560.263. The right to subscribe for the new shares is granted to KEO World, Inc.’s parent company, KEO Aggregator LP, as consideration for the merger. The subscription price per new share shall correspond to the volume-weighted average price (VWAP) of the Company’s shares on Nasdaq Stockholm during the ninety (90) trading days immediately preceding the closing date.

New issue of warrants with deviation from the shareholders’ preferential rights to enable delivery of earn-out shares

The meeting resolved, in accordance with the board of directors’ proposal, on an issue of no more than 49,179,686 warrants with deviation from the shareholders’ preferential rights. The warrants will be issued free of charge to KEO Aggregator LP and entitle the holder to subscribe for new shares in the Company upon satisfaction of a specified earn-out condition. If the condition is not met, the warrants will be cancelled.

Authorization for the board of directors to increase the share capital to facilitate a directed share issue to co-investors

The meeting resolved, in accordance with the board of directors’ proposal, on an authorization for the board of directors to – for the period until the next annual general meeting and on one or several occasions – resolve on the issue of new shares, warrants and/or convertibles, with deviation from shareholders’ preferential rights, corresponding to no more than 17,611,028 new shares. The purpose of the authorization is to facilitate a directed share issue to parties with economic interests in Maha as a result of their participation, through Maha, in a credit facility provided to the KEO Group.

Authorization for the board of directors to increase the share capital to facilitate capital raises

The meeting resolved, in accordance with the board of directors’ proposal, on an authorization for the board of directors to – for the period until the next annual general meeting and on one or several occasions – resolve on the issue of new shares, warrants and/or convertibles, with deviation from shareholders’ preferential rights, corresponding to no more than 41,160,000 new shares at a subscription price of SEK 16 per share. The purpose of the authorization is to facilitate capital raises as part of the transaction and the Company’s ongoing financing, comprising up to three directed share issues to strategic and institutional investors.

Implementation of stock option programs, directed issue of warrants and approval of transfer of warrants

The meeting resolved, in accordance with a proposal from shareholders representing approximately 41.4 percent of the shares and votes in the Company, on the implementation of stock option programs for certain key individuals within Maha and the KEO Group who have been instrumental in initiating, negotiating and executing the transaction. The programs comprise stock options for board members, personnel within Maha and individuals within the KEO Group, for a total of no more than 26,090,412 stock options. Each stock option entitles the holder to acquire one (1) share in the Company at an exercise price corresponding to the share’s quota value (SEK 0.011). The meeting also resolved on a directed issue of warrants to secure the delivery of shares under the programs and on approval of the transfer of warrants to participants.

Incentive program and issuance of warrants to employees and consultants

The meeting resolved, in accordance with the board of directors’ proposal, on an incentive program for executive management and other employees and consultants of the Company and its subsidiaries through issuance of no more than 12,039,349 warrants. The warrants are issued to a group subsidiary for subsequent transfer to participants, and each warrant entitles the holder to subscribe for one (1) new share in the Company at a subscription price corresponding to the volume-weighted average price of the Company’s shares on Nasdaq Stockholm during ninety (90) trading days prior to the date of the general meeting.

Incentive program and issuance of warrants to the members of the board of directors

The meeting resolved, in accordance with the nomination committee’s proposal, on an incentive program for board members of the Company through issuance of no more than 7,944,333 warrants. The warrants are issued to a group subsidiary for subsequent transfer to participants, and each warrant entitles the holder to subscribe for one (1) new share in the Company at a subscription price corresponding to the volume-weighted average price of the Company’s shares on Nasdaq Stockholm during ninety (90) trading days prior to the date of the general meeting.

Amendments of the company’s articles of association

The meeting resolved, in accordance with the board of directors’ proposal, on amendments of the Company’s articles of association regarding the company name. The Company’s name shall be changed to Keo Capital AB. If this name is not approved, one of the following secondary alternatives shall be adopted in order of priority: Keo Credit AB, Keo GCC (Global Credit Card) AB, Keo Credit Solutions AB, Keo Financial Solutions AB, or Keo C AB.

Accelerated vesting of existing incentive program due to the transaction

The meeting resolved, in accordance with the board of directors’ proposal, on accelerated vesting of all warrants allocated under the Company’s existing incentive program for board members (LTIP 9), in light of the material changes to the Company’s scope of operations, core business, shareholder base and corporate structure arising from the transaction. All allocated warrants shall vest from the closing date.

This information was made public, through the agency of the persons below, at 16:15 CET on 28 January 2026.

Amendments to the articles of association
The extra general meeting resolved, in accordance with the board of directors’ proposal, to amend the Company's business name firstly to i) Maha AB, alternatively ii) Maha Capital AB, alternatively iii) Maha Invest AB and lastly to iv) Maha Equity AB.

It was further resolved adjust the object of the Company’s business to own and manage movable and immovable property and conduct other activities compatible therewith.

For detailed terms regarding the resolutions set out above, please refer to the notice, the complete proposals as well as separate press releases which are available at the Company's website, www.maha-capital.com.

The income statements and the balance sheets for the company and the group were approved and the Board of Directors and the CEO were discharged from liability for the financial year 2024.

The Meeting resolved that no dividend shall be paid for the financial year 2024 and that the company’s available funds shall be carried forward in new account.

Paulo Thiago Mendonça, Fabio Vassel, Richard Norris and Halvard Idland were re-elected as members of the Board of Directors. Furthermore, Carlos Gomez-Lackington was new-elected as member of the Board of Directors. Paulo Thiago Mendonça was re-elected as Chairman of the Board.

The Meeting approved fees payable to the members of the Board of Directors and the Chairman of the Board of Directors, including remuneration for committee work, to be as follows:

1. Annual fees of the members of the Board of Directors of SEK 300,000.
2. Annual fee of the Chairman of the Board of Directors of SEK 415,000.
3. Annual fees of SEK 40,000 to members of the Audit, Ethics and Compliance committee, Remuneration committee, and the HSE, Reserves and Sustainability committee. No remuneration shall be paid to the members of the Investment committee.
4. Annual fees of SEK 60,000 to the Chairman of the Audit, Ethics and Compliance committee, Remuneration committee, and the HSE, Reserves and Sustainability committee. No remuneration shall be paid to the Chairman of the Investment committee.
5. Members of the Board of Directors shall be entitled to invoice the company in so far as they perform services outside the Board assignment.

The accounting firm Deloitte AB was re-elected as the auditor of the company, with authorised public accountant Andreas Frountzos as the auditor in charge, for a period until the end of the 2026 Annual General Meeting. The auditor’s fee shall be paid upon approval of their invoice.

The Meeting resolved to approve the company’s remuneration report for the financial year 2024.

The Meeting resolved to authorise the Board of Directors to – for the period up to the next Annual General Meeting and at one or more occasions – resolve on repurchasing so many shares in the company that the company’s holding at no time exceeds 10 percent of all shares in the company and to resolve on the transfer of the company’s own shares, re-purchased in the context of a repurchasing program.

The Meeting resolved to authorise the Board of Directors to – for the period up to the next Annual General Meeting and at one or more occasions – resolve upon issuance of new shares, warrants and/or convertible debentures. Payment may be made in cash, in kind, through set-off of claims or otherwise be conditional. The company’s share capital may be by support of the authorisation be increased by an amount corresponding to 20 percent of the share capital and number of shares in the company as of on the date the Board of Directors make use of the authorisation. Deviation from the shareholders’ preferential rights shall be allowed in situations where a directed issue is deemed more appropriate for the company due to timing, commercial or similar reasons, and in order to enable acquisitions.